Pathway Capital Management
Latest statistics and disclosures from Pathway Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are HIMS, ACLX, GDRX, CRSP, PDD, and represent 94.99% of Pathway Capital Management's stock portfolio.
- Added to shares of these 6 stocks: HIMS (+$6.8M), ACLX, CRSP, GDRX, PDD, NU.
- Started 4 new stock positions in PDD, HIMS, ACLX, CRSP.
- Reduced shares in these 7 stocks: RBRK (-$58M), TOST (-$11M), TTAN (-$6.9M), BRZE, CXM, AMPL, ABNB.
- Sold out of its positions in ABNB, AMPL, BRZE, RBRK, TTAN, CXM, TOST.
- Pathway Capital Management was a net seller of stock by $-71M.
- Pathway Capital Management has $20M in assets under management (AUM), dropping by -77.72%.
- Central Index Key (CIK): 0001037353
Tip: Access up to 7 years of quarterly data
Positions held by Pathway Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Pathway Capital Management
Pathway Capital Management holds 7 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Hims & Hers Health Com Cl A (HIMS) | 33.3 | $6.8M | NEW | 119k | 56.72 |
|
| Arcellx Common Stock (ACLX) | 20.6 | $4.2M | NEW | 51k | 82.10 |
|
| Goodrx Holdings Com Cl A (GDRX) | 20.5 | $4.2M | +69% | 986k | 4.23 |
|
| Crispr Therapeutics Namen Akt (CRSP) | 15.9 | $3.2M | NEW | 50k | 64.81 |
|
| Pdd Holdings Sponsored Ads (PDD) | 4.7 | $951k | NEW | 7.2k | 132.17 |
|
| Nu Holdings Ord Shs Cl A (NU) | 4.6 | $945k | +62% | 59k | 16.01 |
|
| Neuehealth Com New | 0.4 | $75k | 11k | 6.67 |
|
Past Filings by Pathway Capital Management
SEC 13F filings are viewable for Pathway Capital Management going back to 2019
- Pathway Capital Management 2025 Q3 filed Nov. 4, 2025
- Pathway Capital Management 2025 Q2 filed Aug. 4, 2025
- Pathway Capital Management 2025 Q1 filed May 6, 2025
- Pathway Capital Management 2024 Q4 filed Feb. 5, 2025
- Pathway Capital Management 2024 Q3 filed Nov. 5, 2024
- Pathway Capital Management 2024 Q2 filed Aug. 7, 2024
- Pathway Capital Management 2024 Q1 filed May 2, 2024
- Pathway Capital Management 2023 Q4 filed Feb. 8, 2024
- Pathway Capital Management 2023 Q3 filed Nov. 6, 2023
- Pathway Capital Management 2023 Q2 filed Aug. 3, 2023
- Pathway Capital Management 2023 Q1 filed May 10, 2023
- Pathway Capital Management 2022 Q4 filed Feb. 10, 2023
- Pathway Capital Management 2022 Q3 filed Nov. 9, 2022
- Pathway Capital Management 2022 Q2 filed Aug. 10, 2022
- Pathway Capital Management 2022 Q1 filed May 10, 2022
- Pathway Capital Management 2021 Q4 filed Feb. 10, 2022